BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:New and Revised Draft Q&As on Biosimilar Development and the
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-04664-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260512
SUMMARY:FDA comments close: New and Revised Draft Q&As on Biosimilar Devel
 opment and the Biologics Price Competition and Innovation Act\; Draft Gui
 dance for Industry\; Availability
DESCRIPTION:Notice. Federal Register 2026-04664. Docket FDA-2011-D-0611. D
 etails: https://docket-clock.pages.dev/doc/2026-04664/ Official: https://
 www.federalregister.gov/documents/2026/03/10/2026-04664/new-and-revised-d
 raft-qandas-on-biosimilar-development-and-the-biologics-price-competition
 -and
URL:https://www.federalregister.gov/documents/2026/03/10/2026-04664/new-an
 d-revised-draft-qandas-on-biosimilar-development-and-the-biologics-price-
 competition-and
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR